Found 2029 results for "cancer"
Understanding why targeted breast cancer therapies eventually stop working may be the single most consequential challenge in oncology today. Despite…
Venous thromboembolism in hospitalized children has long existed in a clinical gray zone — clinicians managing at-risk pediatric patients have had to…
For women diagnosed with early-stage ovarian cancer, the surgical burden of standard nodal staging may be disproportionate to its clinical benefit — a tension…
Among 3,100 statin-naive adults aged 50–80 who met 2019 ACC/AHA primary prevention criteria and underwent lung cancer screening (LCS) at a Missouri academic…
Precision oncology is undergoing a structural shift — not from a single drug breakthrough, but from an entire treatment paradigm that fuses diagnostic imaging…
A 28-microbial-species risk score derived from shotgun metagenomic sequencing of stool samples in 5,997 Dutch participants predicted incident cancer diagnoses…
Understanding why breast cancer brain metastases resist immunotherapy has long frustrated oncologists. A new spatial immune atlas now offers one of the…
One of the most stubborn obstacles in solid-tumor immunotherapy is antigen escape — when cancer cells shed the surface proteins that immune therapies are…
The prospect of deploying a therapeutic gas — hydrogen — to systematically dismantle a tumor's immune defenses represents a genuinely unconventional frontier…
For the roughly one in six lung cancer patients who never smoked, the question of why they developed the disease has long lacked a satisfying answer. A new…
Lung cancer in never-smokers has long been a clinical puzzle — one that inherited genetics may finally help unravel. A substantial proportion of non-small…
Lung cancer has long been framed as a smoker's disease, yet a meaningful fraction of cases — roughly one in six — arise in people who never touched a…
For the millions of adults who've had high-risk colon polyps removed, the question of how soon to return for a follow-up colonoscopy carries real consequences…
Immunotherapy has transformed cancer treatment, yet a frustrating paradox persists: some patients whose tumors contain tertiary lymphoid structures…
A systematic PubMed review (2020–2026) maps the urological and andrological footprint of GLP-1 receptor agonists — semaglutide, liraglutide, and the dual…
One of oncology's most frustrating realities is that metastasis — responsible for the vast majority of cancer deaths — begins forming its foothold at distant…
Fatal adverse events linked to cancer immunotherapy represent one of oncology's most pressing safety challenges, and how researchers identify these signals…
For the roughly 6–7 million people living with Chagas disease — most of whom will never complete the months-long treatment regimens currently required — a…
Acute lymphoblastic leukemia has long demanded grueling multi-agent chemotherapy regimens that exact severe toxicity — particularly in adult patients whose…
For the millions of adults who receive a high-risk adenoma diagnosis during routine colonoscopy, the standard follow-up timeline directly shapes cancer risk…